David B. Keim
Directeur/Bestuurslid bij Assetlink Corp.
Profiel
David B.
Keim currently works at T3D Therapeutics, Inc., as Director from 2019 and Assetlink Corp., as Secretary & Director.
Actieve functies van David B. Keim
| Bedrijven | Functie | Begin |
|---|---|---|
Assetlink Corp.
 Assetlink Corp. Packaged SoftwareTechnology Services Assetlink Corp. provides software solutions for marketing operations management. Its solutions include strategic planner, marketing workbench, approvals manager, digital asset manager, artwork producer, site builder, knowledge manager, and reports, as well as dashboards that provide single point of controlled access to relevant information for marketing teams and third party vendors. The company was founded by Chetan Saiya in 1997 and is headquartered in Pleasanton, CA. | Directeur/Bestuurslid | - |
T3D Therapeutics, Inc.
 T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Directeur/Bestuurslid | 01-11-2019 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Assetlink Corp.
Assetlink Corp. Packaged SoftwareTechnology Services Assetlink Corp. provides software solutions for marketing operations management. Its solutions include strategic planner, marketing workbench, approvals manager, digital asset manager, artwork producer, site builder, knowledge manager, and reports, as well as dashboards that provide single point of controlled access to relevant information for marketing teams and third party vendors. The company was founded by Chetan Saiya in 1997 and is headquartered in Pleasanton, CA. | Technology Services |
T3D Therapeutics, Inc.
T3D Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology T3D Therapeutics, Inc. engages in the development of its drug product candidate, T3D-959, to treat Alzheimer's disease. The company was founded in 2013 and is headquartered in Research Triangle Park, NC. | Health Technology |
